Barkin J - Search Results

1

Pentosan polysulfate therapy for chronic nonbacterial prostatitis (chronic pelvic pain syndrome category IIIA): a prospective multicenter clinical trial.

Nickel JC, Johnston B, Downey J, Barkin J, Pommerville P, Gregoire M, Ramsey E. Nickel JC, et al. Among authors: barkin j. Urology. 2000 Sep 1;56(3):413-7. doi: 10.1016/s0090-4295(00)00685-3. Urology. 2000. PMID: 10962305 Clinical Trial.

2

Effect of pentosan polysulfate therapy on intravesical potassium sensitivity.

Parsons CL, Forrest J, Nickel JC, Evans R, Lloyd LK, Barkin J, Mosbaugh PG, Kaufman DM, Hernandez-Graulau JM, Atkinson L, Albrecht D; Elmiron Study Group. Parsons CL, et al. Among authors: barkin j. Urology. 2002 Mar;59(3):329-33. doi: 10.1016/s0090-4295(01)01586-2. Urology. 2002. PMID: 11880064 Clinical Trial.

3

Levofloxacin for chronic prostatitis/chronic pelvic pain syndrome in men: a randomized placebo-controlled multicenter trial.

Nickel JC, Downey J, Clark J, Casey RW, Pommerville PJ, Barkin J, Steinhoff G, Brock G, Patrick AB, Flax S, Goldfarb B, Palmer BW, Zadra J. Nickel JC, et al. Among authors: barkin j. Urology. 2003 Oct;62(4):614-7. doi: 10.1016/s0090-4295(03)00583-1. Urology. 2003. PMID: 14550427 Clinical Trial.

4

Randomized, double-blind, dose-ranging study of pentosan polysulfate sodium for interstitial cystitis.

Nickel JC, Barkin J, Forrest J, Mosbaugh PG, Hernandez-Graulau J, Kaufman D, Lloyd K, Evans RJ, Parsons CL, Atkinson LE; Elmiron Study Group. Nickel JC, et al. Among authors: barkin j. Urology. 2005 Apr;65(4):654-8. doi: 10.1016/j.urology.2004.10.071. Urology. 2005. PMID: 15833501 Clinical Trial.

5

Safety and efficacy of up to 900 mg/day polysulfate sodium (elmiron) in patients with interstitial cystitis.

Nickel JC, Forrest J, Barkin J, Payne C, Mosbaugh P. Nickel JC, et al. Among authors: barkin j. Urology. 2001 Jun;57(6 Suppl 1):122-3. doi: 10.1016/s0090-4295(01)01078-0. Urology. 2001. PMID: 11378111 Clinical Trial. No abstract available.

6

Tolerability of 5 mg solifenacin once daily versus 5 mg oxybutynin immediate release 3 times daily: results of the VECTOR trial.

Herschorn S, Stothers L, Carlson K, Egerdie B, Gajewski JB, Pommerville P, Schulz J, Radomski S, Drutz H, Barkin J, Paradiso-Hardy F. Herschorn S, et al. Among authors: barkin j. J Urol. 2010 May;183(5):1892-8. doi: 10.1016/j.juro.2010.01.012. Epub 2010 Mar 29. J Urol. 2010. PMID: 20303119 Clinical Trial.

7

Finasteride monotherapy maintains stable lower urinary tract symptoms in men with benign prostatic hyperplasia following cessation of alpha blockers.

Nickel JC, Barkin J, Koch C, Dupont C, Elhilali M. Nickel JC, et al. Among authors: barkin j. Can Urol Assoc J. 2008 Feb;2(1):16-21. doi: 10.5489/cuaj.520. Can Urol Assoc J. 2008. PMID: 18542722 Free PMC article.

8

A multicenter, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of terazosin in the treatment of benign prostatic hyperplasia.

Elhilali MM, Ramsey EW, Barkin J, Casey RW, Boake RC, Beland G, Fradet Y, Trachtenberg J, Orovan WL, Schick E, Klotz LH. Elhilali MM, et al. Among authors: barkin j. Urology. 1996 Mar;47(3):335-42. doi: 10.1016/S0090-4295(99)80449-X. Urology. 1996. PMID: 8633398 Clinical Trial.

9

Tolerability of solifenacin and oxybutynin immediate release in older (> 65 years) and younger (≤ 65 years) patients with overactive bladder: sub-analysis from a Canadian, randomized, double-blind study.

Herschorn S, Pommerville P, Stothers L, Egerdie B, Gajewski J, Carlson K, Radomski S, Drutz H, Schulz J, Barkin J, Hirshberg E, Corcos J. Herschorn S, et al. Among authors: barkin j. Curr Med Res Opin. 2011 Feb;27(2):375-82. doi: 10.1185/03007995.2010.541433. Epub 2010 Dec 23. Curr Med Res Opin. 2011. PMID: 21175373 Clinical Trial.

10

Canadian Urological Association guideline on male lower urinary tract symptoms/benign prostatic hyperplasia (MLUTS/BPH): 2018 update.

Nickel JC, Aaron L, Barkin J, Elterman D, Nachabé M, Zorn KC. Nickel JC, et al. Among authors: barkin j. Can Urol Assoc J. 2018 Oct;12(10):303-312. doi: 10.5489/cuaj.5616. Can Urol Assoc J. 2018. PMID: 30332601 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

555 results

Search Page

Filters